The Central Pharmacy of Tunisia (PCT) had suffered a net loss of 11.8 million dinars in 2020, against a net profit of 11.9 million in 2019. To this end, the accumulated losses of the public institution amount to 204 million dinars at the end of December 2020 (result included).
According to data from the Ministry of Finance published in its report on state enterprises and institutions, this underperformance is due mainly to the sharp increase in net financial expenses to amount in 2020 to 87 million dinars.
The PCT achieved revenues of 1.6 billion dinars at the end of December 2020, against 1.46 billion a year earlier, recording a 9% increase. As for operating expenses, they remained virtually stable at 1.5 billion dinars.
To this end, the operating result comes out in surplus of 76 million dinars in 2020, against a negative operating result of 68 million in 2019.
The personnel costs of the PCT reached 25.6 million dinars in 2020, compared to 26.5 million in 2019. The public institution employs 662 people.
The outstanding debt reached more than 1.6 billion dinars at the end of December 2020, against 1.5 billion a year earlier.
The PCT shows negative equity of 176 million dinars at the end of 2020.
